设为首页         

资讯内容 Content

[ESC2009]单片复方制剂(SPC)在高血压治疗中的地位及优势--Unger教授访谈
国际循环网版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。

 编辑:国际循环网 时间:2009/9/3 19:00:00    加入收藏
 关键字:SPC 高血压治疗 Unger 倍博特 阿利吉仑 


International Circulation:  When we talk about the period of time to reach target blood pressure, we would think that this combination would help to do that in a shorter period of time.  Would you agree with that?  Is it a shorter period of time than with mono therapy?

《国际循环》:当谈及达到目标血压的时间时,我们想这种联合可能有助于缩短这一时间,您是否同意这种看法?这种联合是否较单药治疗达标时间更短?

Professor Unger:  Yes, I think that if you combine two antihypertensive drugs which attack the problem from different directions, you can assume that there is less time necessary to lower blood pressure and the time to reach target blood pressure is shorter.  The question is rather is it necessary to lower blood pressure very quickly if one wants to go to target or do we have a little bit more time?  I would usually say that you can allow forfour to six weeks to get the patient to target.  You do not have to overdo it in terms of the speed of coming to target blood pressure.

Unger教授:是的,我认为如果联合两种从不同方向针对这一问题的抗高血压药物,我们可以假定降低血压必须的时间更少且达到目标血压的时间缩短。问题在于,如果患者想要达到目标血压,非常迅速地降低血压有必要吗?或者我们有更多一点的时间吗?我通常会说,你可以在4~6周的时间内使患者的血压达标。在达到目标血压的速度上,我们不必过度追求。



上一页  [1]  [2]  [3]  [4]  [5]  下一页

   评论发言          
 
京ICP备15014970号-5   国际循环 版权所有  2008-2022 icirculation.com  All Rights Reserved